Next Conference for Federal Testosterone Treatment Lawsuits Scheduled for July 9th

Share Article

Bernstein Liebhard LLP is representing federal testosterone lawsuit plaintiffs, and anticipates that this conference will provide important updates relevant to those claims.

Free Case Review
We anticipate that the Court will address a number of matters relevant to our clients’ claims, including those pertaining to motions practice and the ongoing case selection process for bellwether trials.

The federal court overseeing hundreds of testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) in the U.S. District Court, Northern District of Illinois, has scheduled the multidistrict litigation’s next Case Management Conference. According to court documents, the Conference will be convened at 11:00 a.m. on July 9th. The Northern District of Illinois is home to more than 1,500 testosterone lawsuits, all of which have been consolidated before a single judge for the purposes of coordinated pretrial proceedings. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is representing clients who have testosterone lawsuits pending in the multidistrict litigation, and we are looking forward to this conference. We anticipate that the Court will address a number of matters relevant to our clients’ claims, including those pertaining to motions practice and the ongoing case selection process for bellwether trials,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by low testosterone therapy medications.

Testosterone Litigation
Court documents indicate that all of the testosterone lawsuits pending in the Northern District of Illinois were filed on behalf of men who allegedly suffered heart attacks, strokes, pulmonary embolism, deep vein thrombosis and other serious cardiovascular problems due to their use of low testosterone therapy. The lawsuits point out that the drugs have only been approved to treat men who suffer from hypogonadism, or low testosterone that is the result of an underlying injury or medical condition. But plaintiffs allege that the manufacturers of prescription testosterone treatments have marketed the products as appropriate treatments for diminished testosterone that is merely associated with the normal male aging process.

According to court documents, the U.S. Food & Drug Administration’s (FDA) launched a review of the cardiovascular risks potentially associated with prescription testosterone products in January 2014.* The results of that review were announced by the FDA on March 3, 2015, at which time the agency ordered the manufacturers of prescription testosterone treatments to update their labels with information regarding a potential association with an increased risk of heart attack and stroke. The FDA also directed that the labels clearly state that the drugs have not been proven safe and effective for treating low testosterone related to male aging.

Men who were allegedly harmed by low testosterone therapy may be eligible to file their own claim in this litigation. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuithub.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website